Pharmamarketeer

Evofem announces additional data from phase 3 ‘AMPOWER’ study of Amphora for hormone─free birth control

Evofem Biosciences, a clinical─stage biopharmaceutical company, reported additional data from its phase 3 ‘AMPOWER’ clinical trial of Amphora for the prevention of pregnancy. These findings reveal that the

Medhc-fases-banner
Advertentie(s)